<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000045366"><TermName>pyrazoloacridine</TermName><TermPronunciation>(PEER-uh-ZOH-loh-A-krih-deen)</TermPronunciation><TermDefinition><DefinitionText>A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called acridines.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000730907" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;pyrazoloacridine&quot;" language="en" id="_3"/><MediaLink ref="CDR0000730906" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;pirazoloacridina&quot;" language="es" id="_4"/><SpanishTermName>pirazoloacridina</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento del c√°ncer. Pertenece al tipo de medicamentos llamados acridinas.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2005-02-15</DateLastModified></GlossaryTerm>
